Skip to main content
Premium Trial:

Request an Annual Quote

Hyseq & MicroDiscovery GmbH


Hyseq of Sunnyvale, Calif., has received US Patent Number 6,355,419, “Preparation of pools of nucleic acids based on representation in a sample.” The invention covers methods for preparing pools for use in hybridizations. Nucleic acids that are represented to a similar degree within a sample are pooled. The method allows the user to control hybridization conditions, such as temperature, ionic strength, and time, in order to increase the likelihood that the nucleic acids within each pool hybridize to a probe with an intensity that is detectable but not saturating to the probe. Additionally, the invention describes arrays and kits that include these pooled nucleic acids, as well as a method for identifying a nucleic acid within a sample.


MicroDiscovery GmbH of Berlin has received German Patent Number DE0010025384A1,”Quantitative measurement of molecule amounts in complex mixtures.” The invention described in the patent relates to a process for the quantitative measurement of molecule amounts in complex mixtures using microarrays and other analogous carriers. Fields of application for this invention are molecular biology, medicine, and the pharmaceutical industry.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.